Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Kaylene, Ready"'
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 17, Iss 1, Pp 1-10 (2019)
Abstract Background The number of individuals meeting criteria for genetic counseling and testing for hereditary cancer syndromes (HCS) is far less than the number that actually receive it. To facilitate identification of patients at risk for HCS, Co
Externí odkaz:
https://doaj.org/article/c2aad1a905fd44348a94149f1b31928a
Autor:
Valentina S. Vysotskaia, Gregory J. Hogan, Genevieve M. Gould, Xin Wang, Alex D. Robertson, Kevin R. Haas, Mark R. Theilmann, Lindsay Spurka, Peter V. Grauman, Henry H. Lai, Diana Jeon, Genevieve Haliburton, Matt Leggett, Clement S. Chu, Kevin Iori, Jared R. Maguire, Kaylene Ready, Eric A. Evans, Hyunseok P. Kang, Imran S. Haque
Publikováno v:
PeerJ, Vol 5, p e3046 (2017)
The past two decades have brought many important advances in our understanding of the hereditary susceptibility to cancer. Numerous studies have provided convincing evidence that identification of germline mutations associated with hereditary cancer
Externí odkaz:
https://doaj.org/article/2583b6401d394609b0e50fd51a04e636
Autor:
Hyunseok P. Kang, Jared R. Maguire, Clement S. Chu, Imran S. Haque, Henry Lai, Rebecca Mar-Heyming, Kaylene Ready, Valentina S. Vysotskaia, Eric A. Evans
Publikováno v:
PeerJ, Vol 4, p e2162 (2016)
Hereditary breast and ovarian cancer syndrome, caused by a germline pathogenic variant in the BRCA1 or BRCA2 (BRCA1/2) genes, is characterized by an increased risk for breast, ovarian, pancreatic and other cancers. Identification of those who have a
Externí odkaz:
https://doaj.org/article/d1fa993c3a444fb7989d48f35b203826
Autor:
Kristin Price, Leslie Bucheit, Katherine Johansen Taber, Valentina Vysotskaia, Kaylene Ready, K. Eerik Kaseniit
Publikováno v:
Cancer. 126:549-558
Background Although management guidelines exist for several genes associated with a 2-fold to 5-fold increase in the relative risk for certain cancers, the value of testing for them remains controversial. Methods De-identified personal and family his
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c706cbd9e70b2f81198b00fbbbbf7bfc
https://doi.org/10.1002/cncr.32572
https://doi.org/10.1002/cncr.32572
Autor:
Kaylene Ready, Kevin R. Haas, Piotr Kaleta, Laura M. Melroy, Shera Kash, Kelly A. Pierce, Dale Muzzey, Hyunseok Kang, Jillian I. Johnson
Publikováno v:
The Journal of Molecular Diagnostics. 21:296-306
Clinical genomic tests increasingly use a next-generation sequencing (NGS) platform due in part to the high fidelity of variant calls, yet rare errors are still possible. In germline DNA screening, failure to correct such errors could have serious co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4297d1513d3c842893c8301a7b10817
https://doi.org/10.1016/j.jmoldx.2018.10.002
https://doi.org/10.1016/j.jmoldx.2018.10.002
Publikováno v:
Biological Research for Nursing
Next-generation sequencing (NGS) technology has led to the ability to test for multiple cancer susceptibility genes simultaneously without significantly increasing cost or turnaround time. With growing usage of multigene testing for inherited cancer,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c05e4c89eba65ff7f3898868aa6d8a
https://doi.org/10.1177/1099800417750746
https://doi.org/10.1177/1099800417750746
Autor:
Valentina, Vysotskaia, K Eerik, Kaseniit, Leslie, Bucheit, Kaylene, Ready, Kristin, Price, Katherine, Johansen Taber
Publikováno v:
Cancer
Background Although management guidelines exist for several genes associated with a 2‐fold to 5‐fold increase in the relative risk for certain cancers, the value of testing for them remains controversial. Methods De‐identified personal and fami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bf25acfec81880d0b5de8b8a6d534204
https://pubmed.ncbi.nlm.nih.gov/31682005
https://pubmed.ncbi.nlm.nih.gov/31682005
Publikováno v:
Genetics in Medicine
Several studies clearly demonstrate increased cancer risks associated with pathogenic variants in certain genes. BRCA1 and BRCA2 are perhaps the best known, but many other genes have been associated with increased cancer risks, including but not limi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4c66d380a889e01a35b40d27a0d6e8a
https://pubmed.ncbi.nlm.nih.gov/30686823
https://pubmed.ncbi.nlm.nih.gov/30686823
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 17, Iss 1, Pp 1-10 (2019)
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice
Background The number of individuals meeting criteria for genetic counseling and testing for hereditary cancer syndromes (HCS) is far less than the number that actually receive it. To facilitate identification of patients at risk for HCS, Counsyl dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a4b38ea2d488be0181f4e352b9ba641
https://pubmed.ncbi.nlm.nih.gov/30651894
https://pubmed.ncbi.nlm.nih.gov/30651894
Autor:
Dale, Muzzey, Shera, Kash, Jillian I, Johnson, Laura M, Melroy, Piotr, Kaleta, Kelly A, Pierce, Kaylene, Ready, Hyunseok P, Kang, Kevin R, Haas
Publikováno v:
The Journal of molecular diagnostics : JMD. 21(2)
Clinical genomic tests increasingly use a next-generation sequencing (NGS) platform due in part to the high fidelity of variant calls, yet rare errors are still possible. In germline DNA screening, failure to correct such errors could have serious co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d8594ba36d4b6105e4f7e7985ccdf23a
https://pubmed.ncbi.nlm.nih.gov/30529126
https://pubmed.ncbi.nlm.nih.gov/30529126